f you want to reduce your DVT rate by 70%, HA-pneumonia and tissue pressure injuries, improve nursing productivity, and save your hospital $130,000 each year for every 1,000 admissions, then contact VasoCARE.
THE LEGACY® IPC
VasoCARE provides the Legacy® IPC, the first and only device that weighs 70 grams, promotes frequent ambulation, improves nurse and patient compliance by over 80%, and reduces DVT by more than 60%. Legacy® IPC can help hospitals save millions each year by preventing HA-DVT, pneumonia, and tissue breakdown.
THE LEGACY® IPC Offers Hospitals Generational Platform Technology in Preventing Deep Vein Thrombosis (DVT), Pneumonia, and/or Tissue Injury.
Occurrence of DVT:
The rate of DVT with active adults is 0.4%. Hospitalize those same individuals and the rate increases to 5% and higher for high-risk patients. Being bed bound plays a major role in the development of DVT.
PCD
VasoCARE chooses to provide Bio Compression’s line of pneumatic compression devices because their devices provide calibrated, gradient compression in treating edema, lymphedema, and venous stasis ulcers.
VeinOPlus® Vascular
VasoCARE provides the VeinOPlus® Vascular device because this advanced neuro-muscular electrical stimulation device improves venous outflow 7x and arterial inflow 5x. Improving perfusion is the key in healing and preventing diabetic foot and venous leg ulcers.
CALL US